Physician profile
Jacob Jensen
NPI 1215306683
$13,811.54
in general payments reported to CMS, 2019-2025
30 companies · $973 in 2025
The $973 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,147 · 2020: $1,100 · 2021: $4,015 · 2022: $2,662 · 2023: $1,624 · 2024: $291 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847 · Travel and Lodging: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.02 |
| Travel and Lodging | $1,040.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,803.16 | 2019-2025 | Grafix Pl, Stravix, Renasys Go V2 Home |
| Empire Medical, INC | $2,443.34 | 2021-2023 | |
| Arthrex, INC. | $1,541.56 | 2021 | |
| Paragon 28, INC. | $1,514.51 | 2019-2025 | Portfolio, Apex 3d, Ankle Fracture |
| Stryker Corporation | $926.10 | 2020-2025 | Augment Injectable, Prostep, Citrefix |
| Osiris Therapeutics INC. | $834.45 | 2019 | |
| Ossio INC | $506.56 | 2022 | |
| Crossroads Extremity Systems, LLC | $395.61 | 2019 | |
| Abbott Laboratories | $264.79 | 2023 | Eterna |
| Horizon Therapeutics Plc | $239.12 | 2023 | Krystexxa |
| Nevro Corp. | $148.51 | 2022 | |
| Cardiovascular Systems INC. | $144.37 | 2022 | |
| Wright Medical Technology, INC. | $138.22 | 2019 | |
| Boston Scientific Corporation | $131.18 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $115.71 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $107.70 | 2019 | |
| Amniox Medical, INC. | $91.31 | 2020 | |
| Angiodynamics, INC. | $85.51 | 2022 | |
| Depuy Synthes Sales INC. | $60.26 | 2025 | Na |
| Zimmer Biomet Holdings, INC. | $55.52 | 2019-2020 | |
| Electronic Waveform Lab, INC. | $49.58 | 2022 | |
| Integra Lifesciences Corporation | $35.78 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.03 | 2025 | |
| Biotissue Holdings INC. | $31.75 | 2021 | |
| Vital Orthopedics LLC | $24.93 | 2025 | |
| Checkpoint Surgical, INC | $23.25 | 2019 | |
| Convatec INC. | $22.90 | 2022 | |
| Melinta Therapeutics, LLC | $22.50 | 2019 | |
| Tactile Systems Technology INC | $15.35 | 2020 | |
| Bard Peripheral Vascular, INC. | $4.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.